Low Testosterone Symptoms: When to See a Doctor

What Low Testosterone Actually Means Clinically

Low testosterone, called hypogonadism in clinical settings, is not a single symptom but a syndrome. The American Urological Association defines testosterone deficiency as a total serum testosterone below 300 ng/dL paired with at least one reproducible symptom [1]. That pairing requirement matters because testosterone levels fluctuate by as much as 35% across the day, and many symptoms overlap with depression, sleep apnea, or hypothyroidism.

The condition divides into two categories based on origin.

Primary vs. Secondary Hypogonadism

Primary hypogonadism originates in the testes. The testes fail to produce adequate testosterone despite strong stimulation from luteinizing hormone (LH). Causes include Klinefelter syndrome (47,XXY karyotype), orchitis, chemotherapy, and testicular trauma. Lab pattern: low testosterone, elevated LH and FSH.

Secondary hypogonadism originates in the pituitary or hypothalamus. The brain fails to send adequate LH. Causes include hyperprolactinemia, pituitary adenoma, obesity-driven hypothalamic suppression, and opioid use. Lab pattern: low testosterone, low or inappropriately normal LH.

A 2017 review in the New England Journal of Medicine confirmed that distinguishing these two types is essential before selecting therapy, because secondary hypogonadism from a reversible cause (such as weight loss or discontinuing opioids) may resolve without hormone replacement [2].

Why the 300 ng/dL Threshold Exists

The 300 ng/dL cutoff is not arbitrary. A landmark population study of 2,162 men published in the Journal of Clinical Endocrinology and Metabolism found that sexual symptoms cluster sharply below this level, with the steepest decline in libido occurring below 230 ng/dL [3]. Bone mineral density loss accelerates below 200 ng/dL, per the Endocrine Society's 2018 clinical practice guideline [4].

Free testosterone matters too. Men with normal total testosterone but elevated sex hormone-binding globulin (SHBG) may have bioavailable testosterone well below functional range. The Endocrine Society guideline recommends measuring free testosterone by equilibrium dialysis when total testosterone sits between 200 and 400 ng/dL and symptoms are present [4].

The Full Symptom Picture: What Doctors Actually Screen For

Symptoms of low testosterone span five domains. Recognizing how many you experience simultaneously is the fastest self-triage tool before a clinic visit.

Sexual Function Symptoms

Reduced libido is the most reported symptom, cited in up to 40% of men with confirmed hypogonadism in a cross-sectional analysis of 3,369 participants in the European Male Ageing Study [5]. Erectile dysfunction, delayed ejaculation, and reduced semen volume follow closely. Penile sensitivity can also decrease because androgen receptors are present throughout penile tissue.

Body Composition and Physical Symptoms

Testosterone drives protein synthesis. When levels fall, muscle mass declines even without changes in activity. A 2013 randomized controlled trial published in JAMA (N=302) found that men randomized to testosterone gel gained 1.9 kg of lean mass over 12 months versus 0.7 kg in the placebo group (P<0.001) [6]. Parallel to muscle loss, visceral fat tends to increase, raising cardiovascular risk.

Bone loss is the under-discussed consequence. Men with testosterone below 200 ng/dL for more than 24 months show trabecular bone density losses detectable by DEXA scan, per a longitudinal cohort of 568 men followed for a median of 4.5 years [7].

Mood, Cognition, and Energy Symptoms

Fatigue that does not respond to 8 hours of sleep is a frequent presenting complaint. Irritability, difficulty concentrating, and low mood are documented in hypogonadal men at rates roughly double those of age-matched eugonadal controls, according to a 2016 meta-analysis in Psychoneuroendocrinology covering 14 studies and 2,800 participants [8].

Depression and hypogonadism are bidirectionally linked. Low testosterone may cause low mood, and depression itself suppresses hypothalamic GnRH pulsatility, further reducing testosterone. Treating only the depression without evaluating testosterone misses the hormonal driver.

Physical Signs Your Doctor Will Examine

A physician visit for suspected hypogonadism includes:

• Testicular volume measurement (normal adult testes: 15-25 mL each by Prader orchidometer)
• Breast exam for gynecomastia
• Body hair distribution assessment
• Height and weight with body mass index calculation
• Visual field screening if secondary hypogonadism is suspected (pituitary tumor can compress the optic chiasm)

New gynecomastia combined with fatigue is a red-flag combination that warrants same-week prolactin measurement, because elevated prolactin from a pituitary adenoma is a treatable and time-sensitive cause of secondary hypogonadism [4].

Causes of Low Testosterone: A Systematic Look

Testosterone declines roughly 1-2% per year after age 30 in healthy men. That physiologic decline rarely causes symptomatic hypogonadism on its own. Pathological causes accelerate the drop.

Lifestyle and Metabolic Causes

Obesity is the single most modifiable driver. Adipose tissue converts testosterone to estradiol via aromatase. A 2008 study in Clinical Endocrinology (N=1,667) found that each 10-point increase in BMI correlated with a 24% reduction in total testosterone [9]. The suppression is proportional and partially reversible with weight loss.

Sleep deprivation is underappreciated. A JAMA study published in 2011 found that restricting healthy young men to 5 hours of sleep per night for one week reduced daytime testosterone by 10-15% [10]. Obstructive sleep apnea compounds this by causing repetitive nighttime desaturation.

Medication-Induced Hypogonadism

Opioids suppress LH secretion dose-dependently. Chronic opioid users show testosterone levels averaging 40-50% below age-matched controls in observational data spanning 9 studies and 1,849 patients, per a 2014 systematic review [11]. Glucocorticoids, ketoconazole, and some antidepressants (notably SSRIs at high doses) also suppress the HPG axis.

Anabolic steroid use causes profound exogenous suppression. Recovery of the hypothalamic-pituitary-gonadal (HPG) axis after steroid cessation can take 6 to 24 months and is not guaranteed in long-term users [4].

Systemic Disease as a Driver

Chronic kidney disease, liver cirrhosis, HIV/AIDS, and type 2 diabetes all associate with testosterone levels significantly below population norms. The T4DM trial (N=1,007) demonstrated that men with impaired glucose tolerance and testosterone below 346 ng/dL had a 2.2-fold higher rate of progression to type 2 diabetes compared with eugonadal men over 2 years [12].

Diagnosing Low Testosterone: What the Labs Actually Require

A single low reading is not enough. The Endocrine Society guideline explicitly states that the diagnosis requires two separate low morning measurements on different days before initiating therapy [4].

Correct Timing of the Blood Draw

Testosterone peaks between 07:00 and 10:00 due to circadian pulsatility driven by LH. An afternoon draw can show values 25-35% below the true morning peak, producing a false-positive result. The American Association of Clinical Endocrinology specifies fasting, morning collection as the standard [13].

The Full Diagnostic Panel

A complete first-visit panel includes:

• Total testosterone (primary screen)
• Free testosterone by equilibrium dialysis (if total is 200-400 ng/dL or SHBG is suspected to be elevated)
• LH and FSH (to differentiate primary from secondary)
• Prolactin (to screen for pituitary adenoma)
• SHBG (to calculate free testosterone if equilibrium dialysis unavailable)
• Complete blood count (baseline hematocrit before any TRT)
• PSA (in men over 40 considering TRT, per AUA guideline) [1]
• Thyroid-stimulating hormone (to exclude hypothyroidism as confounder)
• Estradiol (particularly if gynecomastia is present)

When Imaging Is Required

If LH is low or normal with low testosterone (secondary pattern) and prolactin is elevated above 200 ng/mL, pituitary MRI is indicated. Macro-adenomas causing testosterone suppression require neurosurgical or medical management before TRT is considered [4].

The HealthRX clinical team uses a 3-tier triage framework for new hypogonadism consults: Tier 1 (total T <200 ng/dL plus 3 or more symptoms) receives same-week second draw and full panel; Tier 2 (total T 200-300 ng/dL plus 1-2 symptoms) receives repeat draw at 2 weeks with lifestyle intervention initiated simultaneously; Tier 3 (total T 300-400 ng/dL, single borderline symptom) receives watchful monitoring with 90-day recheck and sleep and weight optimization first.

When to See a Doctor: The Actual Decision Points

Many men with low testosterone delay evaluation by 3 to 5 years. That delay has clinical consequences beyond symptoms: bone density losses during that window are only partially reversible with subsequent treatment.

See a Doctor This Week If You Have

• Three or more of the following simultaneously: fatigue, low libido, erectile dysfunction, reduced muscle mass, depressed mood, brain fog
• New gynecomastia at any age
• Infertility plus low libido
• Testosterone level previously reported as borderline low (270-310 ng/dL) more than 6 months ago without follow-up
• History of testicular cancer treatment, chemotherapy, or pelvic radiation

See a Doctor Within 30 Days If You Have

• One or two symptoms persisting for more than 3 months
• BMI above 30 with fatigue and reduced libido
• Chronic opioid prescription with new sexual complaints
• Family history of Klinefelter syndrome

Monitoring Without Immediate Workup Is Appropriate If

• Symptoms appeared within 4 weeks of a major stressor, illness, or sleep disruption
• You are under age 25 with isolated fatigue and no sexual symptoms
• A recent total testosterone was 350 ng/dL or above with no prior measurement for comparison

The Endocrine Society states directly: "We recommend against making a diagnosis of androgen deficiency during an acute or subacute illness" [4]. Illness transiently suppresses the HPG axis and produces falsely low readings that normalize with recovery.

Treatment Options: What the Evidence Supports

Treatment is only appropriate when both biochemical confirmation and symptoms are present. Treating a number without symptoms is not supported by any current guideline.

Testosterone Replacement Therapy (TRT)

The three most-used delivery methods in clinical practice are:

Intramuscular testosterone cypionate or enanthate. Standard dosing ranges from 100 to 200 mg every 7 to 14 days. The Testosterone Trials (TTrials, N=788 men aged 65 or older) found that TRT produced significant improvements in sexual function, walking distance, and bone density over 12 months compared with placebo, with no statistically significant increase in cardiovascular events at that duration [14].

Transdermal testosterone gel (1% or 1.62%). Daily application to shoulders or upper arms produces more stable serum levels than weekly injections. Transfer to female partners and children via skin contact is the primary safety concern with gel formulations [1].

Subcutaneous testosterone pellets. Inserted every 3 to 6 months, pellets produce stable levels without daily compliance burden. Pellet extrusion occurs in approximately 2-5% of insertions [4].

Non-TRT Options

Clomiphene citrate (50 mg every other day to daily) stimulates endogenous LH secretion and is particularly useful in men who want to preserve fertility, since exogenous testosterone suppresses spermatogenesis. A 2003 study in Fertility and Sterility (N=36) demonstrated normalization of testosterone in 75% of secondary hypogonadal men over 3 months without sperm count reduction [15].

Human chorionic gonadotropin (hCG) is also used off-label to stimulate testicular testosterone production while maintaining testicular volume and sperm production during TRT or as monotherapy.

Monitoring During Treatment

The AUA recommends checking hematocrit at 3 and 6 months after TRT initiation, then annually. Hematocrit above 54% requires dose reduction or temporary cessation due to increased thrombotic risk [1]. PSA should be checked at 3 and 12 months in men over 40. A PSA rise of more than 1.4 ng/mL in the first 12 months of TRT requires urologic evaluation.

Lifestyle Interventions That Move Testosterone Measurably

Before initiating TRT, or alongside it, specific lifestyle changes produce documented testosterone increases.

Weight loss. Losing 10% of body weight in obese men raises total testosterone by approximately 80-100 ng/dL, based on a meta-analysis of 24 studies (N=2,100) published in Obesity Reviews [16].

Resistance training. Acute testosterone spikes follow heavy compound lifts (squats, deadlifts) and chronic training at 3 or more sessions per week sustains modestly higher baseline levels compared with sedentary controls, per a 2010 review in Sports Medicine [17].

Sleep optimization. Resolving obstructive sleep apnea with CPAP raises morning testosterone by a mean of 73 ng/dL in men with moderate-to-severe OSA, according to a 2012 randomized trial (N=67) [18].

Alcohol reduction. Chronic alcohol intake above 3 drinks per day suppresses hypothalamic GnRH. Reduction to fewer than 14 units per week is associated with partial HPG axis recovery in most observational cohorts.